Page 100 - 84_02
P. 100
Effectiveness and pharmacogenetics in a deprescription protocol in chronic pain patients and iatrogenic opioid dependence
2002;110(1):45-50. Guo YH, et al. Gene polymorphisms of OPRM1
A118G and ABCB1 C3435T may influence opioid
19. Dean M, Hamon Y, Chimini G. The human ATP- requirements in Chinese patients with cancer pain.
binding cassette (ABC) transporter superfamily. Asian Pacific journal of cancer prevention : APJCP.
Journal of lipid research. 2001;42(7):1007-17. 2013;14(5):2937-43.
20. Borst P, Evers R, Kool M, Wijnholds J. A family of 33. Zhang Y, Wang D, Johnson AD, Papp AC, Sadee W.
drug transporters: the multidrug resistance-associated Allelic expression imbalance of human mu opioid
proteins. Journal of the National Cancer Institute. receptor (OPRM1) caused by variant A118G. The
2000;92(16):1295-302. Journal of biological chemistry. 2005;280(38):32618-
24.
21. Brambila-Tapia AJ. MDR1 (ABCB1) polymorphisms:
functional effects and clinical implications. Revista de
investigacion clinica; organo del Hospital de
Enfermedades de la Nutricion. 2013;65(5):445-54.
22. Wang J, Guo, X., Yu, S., Zhang, J., Song, J., Ji, M., . .
. Dong, W. MDR1 C3435T polymorphism and
inflammatory bowel disease risk: a meta-analysis. Mol
Biol Rep. 2014;41:2679-85.
23. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M,
Melhem S, et al. Functional analysis of genetic
variation in catechol-O-methyltransferase (COMT):
effects on mRNA, protein, and enzyme activity in
postmortem human brain. American journal of human
genetics. 2004;75(5):807-21.
24. Diatchenko L, Slade GD, Nackley AG, Bhalang K,
Sigurdsson A, Belfer I, et al. Genetic basis for
individual variations in pain perception and the
development of a chronic pain condition. Human
molecular genetics. 2005;14(1):135-43.
25. Kambur O, Mannisto PT. Catechol-O-
methyltransferase and pain. International review of
neurobiology. 2010;95:227-79.
26. Rakvag TT, Klepstad P, Baar C, Kvam TM, Dale O,
Kaasa S, et al. The Val158Met polymorphism of the
human catechol-O-methyltransferase (COMT) gene
may influence morphine requirements in cancer pain
patients. Pain. 2005;116(1-2):73-8.
27. Oneda B, Crettol S, Bochud M, Besson J, Croquette-
Krokar M, Hammig R, et al. beta-Arrestin2 influences
the response to methadone in opioid-dependent
patients. The pharmacogenomics journal.
2011;11(4):258-66.
28. Smith HS. Opioid metabolism. Mayo Clinic
proceedings. 2009;84(7):613-24.
29. Govoni S, Regazzi M, Ranzani GN. Pain and the
pharmacogenetics at the fuzzy border between pain
physiopathology and pain treatment. European Journal
of Pain Supplements. 2008;2(S1):5-12.
30. Befort K, Filliol D, Decaillot FM, Gaveriaux-Ruff C,
Hoehe MR, Kieffer BL. A single nucleotide
polymorphic mutation in the human mu-opioid
receptor severely impairs receptor signaling. The
Journal of biological chemistry. 2001;276(5):3130-7.
31. Fang J, Wang X, He B. Association between Common
Genetic Variants in the Opioid Pathway and Smoking
Behaviors in Chinese Men. Behavioral and Brain
Functions : BBF. 2014;10:2-.
32. Gong XD, Wang JY, Liu F, Yuan HH, Zhang WY,
@Real Academia Nacional de Farmacia. Spain 213
